Upstream Bio, Inc. (UPB) Stock Research

Today

Upstream Bio price target lowered by $18 at Truist, here's why

2:52 PM

Upstream Bio reports Q2 revenue $773,000, consensus $377,250

7:13 AM

Over a week ago

Upstream Bio management to meet with Piper Sandler

Jun 17, 4:18 PM

Upstream Bio presents new responder analyses from VIBRANT trial of verekitug

Jun 14, 4:50 PM

Upstream Bio just downgraded at JPMorgan, here's why

Jun 12, 4:51 AM

Upstream Bio initiated with bullish view at H.C. Wainwright, here's why

Jun 3, 6:02 AM

Upstream Bio presents data from Phase 2 VIBRANT trial of verekitug

May 18, 11:34 AM

Upstream Bio price target lowered by $1 at Mizuho, here's why

May 14, 7:22 AM

Upstream Bio reports Q1 revenue $1.03M, consensus $347,170

May 13, 7:12 AM

Upstream Bio to present new data from Phase 2 Vibrant trial of Verekitug

Apr 17, 7:02 AM

What You Missed On Wall Street On Friday

+28

Mar 27, 4:26 PM

Midday Fly By: Carnival cuts forecast on fuel cost, Novartis to buy Excellergy

+28

Mar 27, 11:53 AM

Wix downgraded, TripAdvisor upgraded: Wall Street's top analyst calls

+14

Mar 27, 9:46 AM

Upstream Bio just downgraded at Evercore ISI, here's why

Mar 27, 6:43 AM

Upstream Bio announces verekitug met the primary endpoint

Mar 1, 11:30 AM

What You Missed On Wall Street On Wednesday

+27

Feb 11, 4:20 PM

Midday Fly By: January payrolls jump, Ford reports mixed Q4

+29

Feb 11, 12:08 PM

Upstream Bio reports results from Phase 2 VALIANT clinical trial

Feb 11, 6:14 AM

Upstream Bio management to meet virtually with Piper Sandler

Jan 20, 2:50 PM

Upstream Bio initiated with bullish view at Mizuho, here's why

Dec 17, 4:12 PM

Upstream Bio initiated with bullish view at LifeSci Capital

Dec 2, 7:13 AM

Upstream Bio initiated with bullish view at Evercore ISI, here's why

Nov 18, 4:53 AM

Upstream Bio files automatic mixed securities shelf

Nov 5, 7:38 AM